In-stent mean luminal diameter also remained constant in the two Taxus groups, at approximately 2.33 mm, but increased in the control patients, from 1.96 to 2.12 mm, between six and 24 months.

The FDA said it is investigating problems with Boston Scientific's Taxus stent after a Michigan hospital suspended use of the devices. William Beaumont Hospital in Royal Oak stopped using the ...

Boston Scientific announced the FDA's decision in a press release April 5, 2005. The new DFU make the Taxus stent the first drug-eluting stent to receive approval for immediate postprocedure MRI.